Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Acrivon Therapeutics Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Acrivon Therapeutics Inc. June 20, 202494.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Acrivon Therapeutics Inc. | Grant or award | +9,366 | — | — |
Questions about Sharon Shacham
What boards is Sharon Shacham on?
Sharon Shacham sits on the boards of Acrivon Therapeutics Inc. and Nasus Pharma Ltd.
How long has Sharon Shacham served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.